Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab

Journal of Rheumatology

Volumn 33, Issue 1, 2006, Pages 82-85

  Schatteman, Lieve ^a   Gyselbrecht, Lieve ^b   De Clercq, Luc ^a   Mielants, Herman ^c,d  

^a SINT AUGUSTINUS HOSPITAL   (Belgium)

^b Municipal Clinic

^c University Hospital Center   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Ankylosing spondylitis; Infliximab; Intraarticular

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CASE REPORT; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KNEE ARTHRITIS; LONG TERM CARE; MALE; MONARTHRITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUESTIONNAIRE; REFRACTORY INFLAMMATORY MONOARTHRITIS; REMISSION; SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TREATMENT OUTCOME;

EID: 30144439889     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gratacos J, Collado A, Filella X, et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31.
2. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
3. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab - a double-blind, placebo-controlled multicenter trial. Lancet 2002;359:1187-93.
4. Van den Bosch F, Kruithof E, Baeten D, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. Arthritis Rheum 2002;46:755-6.
5. Kruithof E, Van den Bosch F, Baeten D, et al. Repeated infusions of infliximab, a chimeric anti-TNF alpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rhem Dis 2002;61:207-12.
6. Braun J, Brandt J, Listing J, et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Arthritis Rheum 2003;48:2224-33.
7. Baraliakos X, Listing J, Brandt J, Rudwaleit M, Sieper J, Braun J. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. Arthritis Res Ther 2005;7:R439-44. E-pub 2005 Feb 21
8. Nikas SN, Temekonidis TJ, Zikou AK, Argyropoulou MI, Efremidis S, Drosos AA. Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study. Ann Rhem Dis 2004;63:102-3.
9. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of New York criteria. Arthritis Rheum 1984;27:361-8.
10. Baeten D, Kruithof E, Van den Bosch F, et al. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondyloarthropathy: histologie findings in eight patients from an open-label pilot study. Arthritis Rheum 2001;44:186-95.
11. Baeten D, Demetter P, Cuvelier C, et al. Macrophages expressing CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002;196:343-50.
12. Dreher R, Flaig W, Leitzke D. Treatment of rheumatoid arthritis by intra-articular injections of TNF alpha blockers [abstract]. Arthritis Rheum 2001;44 Suppl:15.
13. Kellner H, Kroetz M, Schattenkirchner M, Kellner W. Successful therapy of sacroiliitis in AS patients by intraarticular injection of infliximab [abstract]. Arthritis Rheum 2002;46 Suppl:S431.
14. Conti F, Priori R, Chimenti MS, et al. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99m Tc-infliximab. Arthritis Rheum 2005;52:1224-6.
15. Andonopoulos AP, Meimaris N, Daoussis D, Bounas A, Yiannopoulos G. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behcet's disease. Clin Exp Rheumatol 2003;21 Suppl 30:557-8.
16. Bokarewa M, Tarkowski A. Local infusion of infliximab for treatment of acute joint inflammation. Ann Rheum Dis 2003;62:783-4.